Additionally, Karki et al. [125], who have evaluated the potential of PL in breast and lung cancers, have reported that the compound was effective in pancreatic cancer cells as well, mainly through the suppression of the Sp transcription factors and their regulated genes. Here, TFF2 is linked to lung cancer.